Overview
Akira Matsushima practices in Shinshu, Japan. Matsushima is rated as an Experienced expert by MediFind in the treatment of Multiple System Atrophy. Their top areas of expertise are Spinocerebellar Ataxia Type 31, Cerebellar Multiple System Atrophy, Spinocerebellar Ataxia Type 6, and Drug Induced Dyskinesia.
Their clinical research consists of co-authoring 25 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Multiple System Atrophy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Spinocerebellar Ataxia Type 31Matsushima isDistinguished. Learn about Spinocerebellar Ataxia Type 31.
- Advanced
- Cerebellar Multiple System Atrophy
- Spinocerebellar Ataxia Type 6Matsushima isAdvanced. Learn about Spinocerebellar Ataxia Type 6.
- Experienced
- Acute Cerebellar AtaxiaMatsushima isExperienced. Learn about Acute Cerebellar Ataxia.
- Alternating Hemiplegia of ChildhoodMatsushima isExperienced. Learn about Alternating Hemiplegia of Childhood.
- CACH SyndromeMatsushima isExperienced. Learn about CACH Syndrome.
- Cardiac AmyloidosisMatsushima isExperienced. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyMatsushima isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Drug Induced DyskinesiaMatsushima isExperienced. Learn about Drug Induced Dyskinesia.